Neurosense Therapeutics Ltd
NRSN1.150USD
+0.070+6.52%
交易中 （美东）报价延迟15分钟
26.72M总市值
亏损市盈率 TTM
关于 Neurosense Therapeutics Ltd 公司
NeuroSense Therapeutics Ltd 是一家位于以色列的临床阶段制药公司。该公司活跃于药物开发和治疗领域，为肌萎缩侧索硬化症 (ALS) 患者以及其他神经退行性疾病提供药物。该公司的主要候选产品 PrimeC 是一种由特定比例的药物组成的固定剂量组合口服制剂。除了 PrimeC 之外，该公司还启动了阿尔茨海默病和帕金森病的研究和开发工作
公司简介
公司代码NRSN
公司名称Neurosense Therapeutics Ltd
上市日期Dec 09, 2021
CEOMr. Alon Ben-Noon
员工数量15
证券类型Ordinary Share
年结日Dec 09
公司地址11 Hamenofim St.
城市HERZLIYA
上市交易所NASDAQ Capital Market Consolidated
国家Israel
邮编4672562
电话97299531142
网址https://www.neurosense-tx.com/
公司代码NRSN
上市日期Dec 09, 2021
CEOMr. Alon Ben-Noon
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+3.04%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+4.55%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+54.22%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+3.04%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+4.55%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+54.22%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
持股股东
占比
Ben-Noon (Alon)
13.24%
Rimon Gold Assets Ltd
9.60%
Gordon Ariel S
4.31%
Eisenberg (Or)
2.00%
Tracik (Ferenc)
0.79%
Other
70.05%
持股股东
持股股东
占比
Ben-Noon (Alon)
13.24%
Rimon Gold Assets Ltd
9.60%
Gordon Ariel S
4.31%
Eisenberg (Or)
2.00%
Tracik (Ferenc)
0.79%
Other
70.05%
股东类型
持股股东
占比
Individual Investor
21.38%
Corporation
9.60%
Investment Advisor
0.29%
Research Firm
0.21%
Venture Capital
0.14%
Hedge Fund
0.11%
Investment Advisor/Hedge Fund
0.07%
Other
68.21%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
37
7.63M
31.79%
+136.65K
2025Q1
39
7.45M
37.28%
+353.50K
2024Q4
38
7.90M
34.02%
+1.29M
2024Q3
32
5.18M
22.45%
-1.31M
2024Q2
35
6.62M
30.57%
+1.57M
2024Q1
38
5.18M
33.20%
-953.28K
2023Q4
38
5.12M
32.81%
-1.05M
2023Q3
33
5.76M
47.99%
-945.27K
2023Q2
33
6.46M
53.11%
+1.06M
2023Q1
30
5.11M
43.34%
-185.85K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Ben-Noon (Alon)
3.18M
13.24%
+93.67K
+3.04%
Apr 07, 2025
Rimon Gold Assets Ltd
2.30M
9.6%
+2.30M
--
Dec 02, 2024
Gordon Ariel S
1.03M
4.31%
+1.30K
+0.13%
Dec 31, 2023
Eisenberg (Or)
480.92K
2%
+20.92K
+4.55%
Apr 07, 2025
Tracik (Ferenc)
189.62K
0.79%
+66.67K
+54.22%
Apr 07, 2025
Russek-Blum (Niva)
75.43K
0.31%
+10.00K
+15.28%
Apr 07, 2025
Leuchtenberger (Mark W)
64.00K
0.27%
--
--
Apr 07, 2025
Morgan Stanley & Co. LLC
50.50K
0.21%
-52.08K
-50.77%
Mar 31, 2025
Meitav Dash Investments Ltd.
40.00K
0.17%
--
--
Mar 31, 2025
XTX Markets LLC
33.71K
0.14%
-8.19K
-19.55%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
